Filing Details
- Accession Number:
- 0001209191-23-047608
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-29 16:40:06
- Reporting Period:
- 2023-08-28
- Accepted Time:
- 2023-08-29 16:40:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1382101 | Sutro Biopharma Inc. | STRO | Biological Products, (No Disgnostic Substances) (2836) | 452441988 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1966915 | Brunilda Shtylla | C/O Sutro Biopharma, Inc. 111 Oyster Point Blvd. South San Francisco CA 94080 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-08-28 | 15,428 | $4.71 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.635 to $4.745, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The total number of shares of the Issuer's Common Stock owned before giving effect to the reported sale included 2,500 shares previously acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions that are exempt pursuant to Rules 16b-3(c) and 16b-3(d).
Billionaire Hedge Funds
